Delivery Order SPE2DB22D1002-SPE2DB25FLCX3
Award Date 6/2/25
Potential Completion Date 6/3/25
Potential Value $11K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 31, 2025, for the supply of Emgality 300 mg (100 mg x3 syringes) with a ceiling value of $1,905.64. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the pharmaceutical product Emgality 120 mg/mL pen on May 20, 2025, with a ceiling value of $1,037.40. This firm fixed-price contract is non-competitive and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle valued through December 2026. The place of performance is...
- The Defense Logistics Agency awarded a delivery order valued at $1,001.26 to AmerisourceBergen Drug Corp for the supply of Emgality 120 mg/ml syringes, with an ultimate completion date of November 14, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded a delivery order valued at $1,547.00 to AmerisourceBergen Drug Corp for the supply of Emgality 300 mg (100 mg x3 syringe/mL) on November 10, 2025, with an ultimate completion date of November 12, 2025. This is a firm fixed price delivery order with no set-aside designation, meaning it was awarded through open competition. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, the headquarters location of the prime contractor....
- The Defense Logistics Agency awarded a delivery order valued at $3,116.22 to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Emgality 120 mg/ml in pen format. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under an open competition process. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 15, 2025. Emgality is a monoclonal antibody treatment...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $2,562.51 on September 18, 2025, for the supply of Emgality 300 mg (100 mg x3 syringe/mL) under a Defense Logistics Agency Medical Supply Chain contract. The award is a firm fixed price, non-set-aside delivery order with an ultimate completion date of September 19, 2025. Performance will take place at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a single task against...
- The Defense Logistics Agency awarded a delivery order valued at $7,793.53 to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of Emgality 120mg/ml, a migraine treatment medication. The contract is classified as a non-set-aside, competitively awarded delivery order with firm fixed pricing and an ultimate completion date of October 30, 2025. Performance will be conducted at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a $2,062.98 delivery order to AmerisourceBergen Drug Corp for Emgality 120 mg/mL pen injectors under a firm fixed price contract. The delivery order, issued on October 30, 2025, with an ultimate completion date of October 31, 2025, represents a child contract leveraging AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. This award was competitively awarded with no set-aside designation and will be performed at...
- The Defense Logistics Agency awarded a $2,172.80 delivery order to AmerisourceBergen Drug Corp for Emgality 120 mg/ml pen/ml on September 22, 2025, with completion expected by September 23, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Emgality is a CGRP monoclonal antibody used for migraine prevention, indicating this order supports the federal government's...
- The Defense Logistics Agency awarded a delivery order valued at $1,004.40 to AmerisourceBergen Drug Corp for Emgality 120 mg/ml pre-filled pens on November 18, 2025, with an ultimate completion date of November 19, 2025. The contract utilizes a firm fixed-price structure with no set-aside designation and will be performed at the awardee's corporate office in Conshohocken, Pennsylvania. Emgality is a monoclonal antibody used for migraine prevention, representing a specialized pharmaceutical...